Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs

Proposed acquisition builds on existing collaboration between Decibel and Regeneron, will accelerate and further resource key gene therapy programs for hearing loss Decibel’s lead...

Related Keywords

United States ,France ,Germany ,Spain ,Boston ,Massachusetts ,Laurencee Reid ,Wilmer Cutler Pickering Hale ,Julie Seidel ,Alexandra Bowie ,Georged Yancopoulos ,Rosen Katz ,Chris Railey ,Vesna Tosic ,Decibel Therapeutics Inc ,European Medicines Agency ,Lipton ,Exchange Commission ,Twitter ,Drug Administration ,Regeneron Pharmaceuticals Inc ,Regeneron Genetics Center ,Regeneron Investor Relations Department ,Healthcare Products Regulatory Agency ,Centerview Partners ,Leerink Partners ,Nasdaq ,Symphony Acquisition Sub Inc ,Decibel Therapeutics ,Decibel Board ,Chief Executive Officer ,Chief Scientific Officer ,Symphony Acquisition Sub ,Biologics License Application ,Marketing Authorization Application ,Regeneron Pharmaceuticals ,Product Candidates ,Quarterly Reports ,Annual Reports ,Tender Offer Statement ,Recommendation Statement ,Decibel Investor Relations ,Investor Relations Department ,Markets ,